X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
USA (Orange Book)
Europe
0
Canada
Australia
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
https://www.prnewswire.com/news-releases/medison-pharma-announces-public-formulary-listing-of-qinlock-ripretinib-in-canadian-provinces-ontario-and-quebec-for-advanced-gastrointestinal-stromal-tumor-gist-treatment-301942841.html
https://www.prnewswire.com/news-releases/new-therapy-to-treat-rare-gastrointestinal-stromal-tumour-approved-for-new-zealand-patients-301725538.html
https://www.biospace.com/article/releases/deciphera-announces-approval-of-qinlock-in-the-united-kingdom-for-the-treatment-of-fourth-line-gastrointestinal-stromal-tumor/
https://www.businesswire.com/news/home/20211012005254/en/Deciphera-Announces-Approval-of-QINLOCK%C2%AE-in-Switzerland-for-the-Treatment-of-Fourth-Line-Gastrointestinal-Stromal-Tumor
https://www.foxchase.org/news/2021-09-17-update-on-invictus-trial-shows-improved-overall-median-survival-in-gist-patients-using-ripretinib
https://www.prnewswire.com/il/news-releases/medison-pharma-enters-exclusive-distribution-agreement-with-deciphera-pharmaceuticals-to-commercialize-qinlock-ripretinib-in-a-multi-regional-agreement-301167378.html
https://www.biospace.com/article/releases/deciphera-presents-data-from-qinlock-ripretinib-program-in-patients-with-gastrointestinal-stromal-tumor-at-the-european-society-for-medical-oncology-esmo-virtual-congress-2020-/
https://markets.businessinsider.com/news/stocks/deciphera-announces-publication-of-qinlock-ripretinib-phase-1-study-results-in-patients-with-gastrointestinal-stromal-tumor-in-journal-of-clinical-oncology-1029510313
https://www.globenewswire.com/news-release/2020/08/04/2072363/0/en/Zai-Lab-Announces-NDA-for-Ripretinib-Granted-Priority-Review-by-China-s-NMPA.html
https://www.fiercepharma.com/marketing/deciphera-fills-where-blueprint-falls-short-early-fda-nod-for-qinlock-rare-stomach-cancer
https://www.prnewswire.com/news-releases/pantherx-rare-pharmacy-selected-by-deciphera-pharmaceuticals-to-distribute-qinlock-ripretinib-for-gastrointestinal-stromal-tumor-gist-patients-301060948.html
https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-fourth-line-treatment-advanced-gastrointestinal-stromal-tumors
https://www.businesswire.com/news/home/20191216005211/en/Deciphera-Pharmaceuticals-Announces-Submission-New-Drug-Application/?feedref=JjAwJuNHiystnCoBq_hl-WFAllVCLJFCqzlmaJ8DKHU4plfPZtlGYRDUHCSmgbii6XkLWuQZD-HgGRnjQvCyg3iCfEFIaJW7-otp9V1XQiK2eHTJy3ZqOEt7kKgLu20J
Market Place
Share 
